App and home delivery aim to keep youth HIV-free

NCT ID NCT07438041

Not yet recruiting Prevention Sponsor: Westat Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This study tests a new way to help young people (ages 13-24) stick with PrEP, a medication that prevents HIV. Participants get PrEP delivered to a community spot (like home or a mobile van) and use a smartphone app for reminders and support. The goal is to see if this combo improves adherence and persistence at 6 and 9 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

posterior leukoencephalopathy syndrome HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV PREP PREP ADHERENCE

Contacts and locations

Locations

Baylor College of Medicine

Houston, Texas, 77030, United States
Emory Atlanta Adolescent Consortium

Atlanta, Georgia, 30322, United States
Johns Hopkins University

Baltimore, Maryland, 21287, United States
San Francisco Department of Public Health

San Francisco, California, 94102, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.